Symposium Speakers
The BIBC symposium will be showcasing cutting edge research in brain cancer biology and novel technologies
By bringing together a multi-disciplinary group of researchers, we can advance technological innovations for brain cancer patients.
Keynote Speakers
Confirmed Speakers
Peter Fecci, MD, PhD, Duke University
Dolores Hambardzumyan, PhD, MBA, Icahn School of Medicine at Mount Sinai
Shawn Hervey-Jumper, MD, University of California San Francisco
Irina Balyasnikova, PhD, Northwestern University
Ali Shilatifard, PhD, Northwestern University
Ranjit Bindra, MD, PhD, Yale
Yon Son Betty Kim, MD, PhD, MD Anderson Cancer Center
Robert Prins, PhD, University of California Los Angeles
Shawn Hingtgen, PhD, University of North Carolina
Roland Friedel, PhD, Icahn School of Medicine at Mount Sinai
Balveen Kaur, PhD, The University of Texas Health Science Center at Houston
David Reardon, MD, Dana-Farber Cancer Institute and Harvard Medical School
Hong Chen, PhD, Washington University in St. Louis
Ananth V. Annapragada, PhD, Texas Children’s Hospital
Jose Javier Bravo-Cordero, PhD, Icahn School of Medicine at Mount Sinai
Robert G. Thorne, PhD, Denali Therapeutics and the University of Minnesota – Minneapolis
